Louie Alexander V, Li Lihua, Jenkyn Krista Bray, Allen Britney, Rodrigues George B, Warner Andrew, Palma David A, Shariff Salimah Z
Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
J Thorac Dis. 2018 Mar;10(3):1440-1448. doi: 10.21037/jtd.2018.02.05.
As the value of radiotherapy (RT) in intensive care unit (ICU) patients with lung cancer is of uncertain efficacy, we evaluated characteristics, outcomes and RT utilization for such patients in Ontario, Canada.
Multiple administrative databases were linked deterministically using unique encoded identifiers to identify eligible patients between April 1, 2007, and March 31, 2014. Differences in patient, treatment, institution and tumor characteristics between RT and non-RT groups at the level of episode of care were compared. Overall survival (OS) was evaluated using the Kaplan-Meier method, with differences compared using the log-rank test. Univariable and multivariable Cox proportional hazard modeling were performed to assess the effect of RT on survival.
RT was delivered in 133 episodes of care to 1.0% (n=131) of the 13,739 unique patients with lung cancer. RT delivery was associated with younger age (median 65 68, P<0.001), ventilation (79.8% 38.2%, P<0.001) and longer ventilation duration (median 6 0 days, P<0.001). Pre-ICU disposition via transfer (35.3% 9.7%) or the emergency room (ER) (28.6% 21.9%) was more likely in the RT group (P<0.001). RT delivery varied, with half of the regions treating ≤5 patients each. ICU discharge was common in both RT (n=75, 56.4%) and non-RT (n=10,405, 71.4%) cohorts. One-year OS was poor in both groups, but most notably in the RT group (11.3% 42.4%). RT was associated with inferior 1-year OS on unadjusted modeling (HR =1.99, P<0.001), with ventilation and pre-ICU disposition adjusting this finding towards the null on multivariable modeling (HR =1.17, P=0.095).
Major geographic disparities exist in the rare use of RT for lung cancer in the ICU. A significant proportion of patients receiving RT achieve discharge and a minority achieve prolonged survival, suggesting that RT use may not be futile.
由于放射治疗(RT)在重症监护病房(ICU)肺癌患者中的疗效尚不确定,我们评估了加拿大安大略省此类患者的特征、结局和RT使用情况。
使用唯一编码标识符确定性地链接多个管理数据库,以识别2007年4月1日至2014年3月31日期间符合条件的患者。比较了RT组和非RT组在护理期间患者、治疗、机构和肿瘤特征的差异。采用Kaplan-Meier方法评估总生存期(OS),并使用对数秩检验比较差异。进行单变量和多变量Cox比例风险建模,以评估RT对生存的影响。
在13739例肺癌患者中,133例接受了RT治疗,占1.0%(n = 131)。RT治疗与患者年龄较轻(中位数65对68,P < 0.001)、通气(79.8%对38.2%,P < 0.001)以及通气时间较长(中位数6对0天,P < 0.001)相关。RT组通过转运(35.3%对9.7%)或急诊室(ER)(28.6%对21.9%)进行ICU前处置的可能性更高(P < 0.001)。RT治疗情况各异,半数地区每个地区治疗的患者≤5例。RT组(n = 75,56.4%)和非RT组(n = 10405,71.4%)的患者从ICU出院情况都很常见。两组的1年总生存率都很低,但RT组尤为明显(11.3%对42.4%)。在未调整的模型中,RT与较差的1年总生存率相关(HR = 1.99,P < 0.001),在多变量模型中,通气和ICU前处置使这一结果向无效方向调整(HR = 1.17,P = 0.095)。
ICU中肺癌患者RT使用罕见,存在显著的地理差异。相当一部分接受RT治疗的患者实现了出院,少数患者实现了长期生存,这表明RT的使用可能并非徒劳。